Global Fibromyalgia Market Landscape 2018: Diagnosis & Treatment, Market Share, Demand, New Opportunities and Forecast 2027

The Fibromyalgia Market Report provides the present treatment practices, rising drugs, market share of the individual therapies, current and forecasted market size of Fibromyalgia from 2018 to 2027 divided by seven major markets and also covers current treatment practice/algorithm, drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market. It delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Fibromyalgia in the US, EU5 (Germany, France, Spain, Italy and United Kingdom), and Japan.

Fibromyalgia (FM) is a medical condition characterized by chronic widespread pain and a heightened pain response to pressure. Other symptoms include tiredness to a degree that normal activities are affected, sleep issues and troubles with memory. Some individuals also report restless legs syndrome, bowel or bladder problems, numbness and tingling and sensitivity to noise, lights or temperature. Fibromyalgia is often associated with depression, anxiety and post traumatic stress disorder. Other kinds of chronic pain are also frequently present.

The cause of fibromyalgia is unknown; however, it is believed to involve a mixture of genetic and environmental factors, with each playing a substantial role. The condition runs in families and many genes are believed to be involved. Environmental factors may include psychological stress trauma and certain infections. The pain appears to result from processes in the central nervous system and also the condition is referred to as a "central sensitization syndrome".  Fibromyalgia is recognized as a disorder by the United States country|North American nation} National Institutes of Health and the American college of rheumatology. There's no specific diagnostic assay. Diagnosis involves 1st ruling out other potential causes and verifying that a set number of symptoms are present.

The treatment of fibromyalgia are often difficult. Recommendations usually include getting enough sleep, exercising regularly and eating a healthy diet. cognitive behavioural therapy (CBT) may also be useful. The medications duloxetine, milnacipran or pregabalin may be used. Use of opioid pain medication is controversial, with some stating their use is poorly supported by evidence and others saying that weak opioids may be reasonable if other medications are not effective. Dietary supplements additionally lack evidence to support their use. While fibromyalgia can last a long time, it doesn't result in death or tissue damage.

Fibromyalgia is estimated to affect 2–8% of the population. Women are affected about twice as compared to men. Rates appear similar in different areas of the globe and among different cultures. Fibromyalgia was first defined in 1990, with updated criteria in 2011. There is controversy about the classification, diagnosis and treatment of fibromyalgia. While some feel the diagnosis of fibromyalgia may negatively affect a person, other research finds it to be beneficial.

Key points Covered in this Report:

Fibromyalgia Market (7MM) and forecasting
Fibromyalgia Sales forecasting
Fibromyalgia Market segments
Fibromyalgia Epidemiology
Pipeline products and technologies
Fibromyalgia Competitive landscape, SWOT analysis
Fibromyalgia Market Driver’s and barriers
Fibromyalgia Key Companies and Funding
Additionally, the Report highlights the frontrunners, the drivers and barriers for the Fibromyalgia market, as well as treatment algorithm, current treatments & advancements are included.

Get a Sample of Fibromyalgia Market research report from:

https://www.marketreportsworld.com/enquiry/request-sample/10918651

Points covered in the Fibromyalgia Market research reports:

Fibromyalgia - Disease Understanding and Treatment Algorithm:

Fibromyalgia (FM) is a common and complex chronic pain disorder that affects people physically, mentally and socially. It is characterized by chronic widespread pain, multiple tender points, abnormal pain processing, sleep disturbances, fatigue and often psychological distress. Fibromyalgia is mainly caused due to genetic conditions, but the actual cause is still unknown. Most researchers agree that FM is a disorder of central processing with neuroendocrine/neurotransmitter dysregulation.

The Fibromyalgia market report gives the thorough understanding of the Fibromyalgia by including details such as disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends. It also provides treatment algorithms and treatment guidelines for Fibromyalgia in the US, Europe, and Japan.

Fibromyalgia Epidemiology:

The Fibromyalgia epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology scenario of Fibromyalgia in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.

According to National Fibromyalgia Association, the disorder affects an estimated 10 million people in the U.S. and an estimated 3-6% of the world population. The diagnosis is usually made between the ages of 20 to 50 years, but the incidence rises with age so that by age 80, approximately 8% of adults meet the American College of Rheumatology [ACR] classification criteria of fibromyalgia.

Have a Query, Ask our expert:

https://www.marketreportsworld.com/enquiry/pre-order-enquiry/10918651

Fibromyalgia Drug Chapters:

This segment of the Fibromyalgia report encloses the detailed analysis of marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Although there is no cure for Fibromyalgia, the current treatment focusses on reduction of the symptoms. Based on the drug classes, the Fibromyalgia therapeutic market is segmented as Antidepressants (Venlafaxine, Duloxetine HCl, Milnacipran HCl), Anticonvulsants (Pregabalin, Gabapentin), Muscle relaxants and Analgesics. While drug treatments are available for the symptoms of fibromyalgia, yet their efficacy varies from patient to patient, and significant side effects can limit benefits or preclude use of these medications. Thus, there is a continued need for additional effective and tolerable treatment options for patients to improve their daily functioning.

Fibromyalgia Market Outlook:

The Fibromyalgia market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a through detail of market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

Key players such as Aptinyx, Astellas Pharma and Innovative med concepts are involved in developing therapies for Fibromyalgia. Expected launch of emerging therapies such as NYX-2925 (Aptinyx), ASP0819 (Astellas Pharma) and IMC-1 (Innovative med concepts) will significantly impact the Fibromyalgia market during the study period (2016-2027).

Fibromyalgia Drugs Uptake:

This section focusses on the rate of uptake of the potential drugs recently launched in the market or will get launched in the market during the study period from 2016-2027. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Fibromyalgia Report Insights:

Patient Population
Therapeutic Approaches
Pipeline Analysis
Market Size and Trends
Market Opportunities
Impact of upcoming Therapies
Fibromyalgia Report Key Strengths

10 Years Forecast
7MM Coverage
Epidemiology Segmentation
Sub-type Segmentation
Key Cross Competition
Highly Analyzed Market
Drugs Uptake
Fibromyalgia Report Assessment

Current Treatment Practices
Unmet Needs
Pipeline Product Profiles
Market Attractiveness
Market Drivers and Barriers
Price of Report: $6250(Single User Licence)

Purchase the Fibromyalgia Market Report at:

https://www.marketreportsworld.com/purchase/10918651

The Report provides the 10 years forecast from 2018 to 2027 segmented by seven major markets, enabling to understand the potential of the Fibromyalgia in the respective markets. The epidemiology data is presented with graphs and tables to provide a clear assessment of the landscape.

 

Market is changing rapidly with the ongoing expansion of the industry. Advancement in the technology has provided today's businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies with a head start in planning and an edge over the competitors. Market Reports World is the credible source for gaining the market reports that will provide you with the lead your business needs.

3rd Floor, Silver Spring, Sahyadri farms,
Opp Prabhavee Tech Park,
Baner - Mhalunge Road, Baner, Pune 411045

This release was published on openPR.